You have 9 free searches left this month | for more free features.

Condition

Neoadjuvant Operable Breast Cancer (1)

Pathological Response Rate (1)

Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Centre Jean Perrin (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

UNICANCER (1)

Collaborator

NanoString Technologies, Inc. (1)

Pfizer (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

fluorouracile

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

Completed

Neoadjuvant Operable Breast Cancer

Fluorouracile
+4 more

Paris, France
+1 more

Mar 14, 2022

Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated

Terminated

Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated

Oxaliplatin
+2 more

Villejuif, Val de Marne, France

Institut Gustave Roussy

Feb 9, 2016

Pathological Response Rate Trial in France (vectibix, fluorouracile, Epirubicine)

Completed

Pathological Response Rate

vectibix
+4 more

Clermont-Ferrand, France
+11 more

Mar 20, 2014